Diagnostic tools for human African trypanosomiasis elimination and clinical trials: The DiTECT-HAT project
Background Trypanosoma brucei gambiense (Tbg) causes human African trypanosomiasis (HAT), one of the neglected tropical diseases targeted for elimination. Integration of diagnosis and case management into the general health system, sustainable monitoring of eliminated foci and development of safe an...
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Conference Paper Abstract |
| Lenguaje: | Inglés |
| Publicado: |
BMJ
2017
|
| Materias: | |
| Acceso en línea: | https://hdl.handle.net/10568/80002 |
Ejemplares similares: Diagnostic tools for human African trypanosomiasis elimination and clinical trials: The DiTECT-HAT project
- Performance of clinical signs and symptoms, rapid and reference laboratory diagnostic tests for diagnosis of human African trypanosomiasis by passive screening in Guinea: a prospective diagnostic accuracy study
- Monitoring the elimination of gambiense human African trypanosomiasis in the historical focus of Batié, South-West Burkina Faso
- Passive surveillance of human African trypanosomiasis in Côte d'Ivoire: Understanding prevalence, clinical symptoms and signs, and diagnostic test characteristics
- The role of animal reservoirs of rhodesiense human African trypanosomiasis (r-HAT)
- Cattle diseases and trypanosomiasis in the Gambia. I. Clinical studies
- Carbon sequestration: pulling off an ecological hat-trick?